These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29496635)

  • 21. Vocal training, levodopa, and environment effects on ultrasonic vocalizations in a rat neurotoxin model of Parkinson disease.
    Kelm-Nelson CA; Brauer AF; Ciucci MR
    Behav Brain Res; 2016 Jul; 307():54-64. PubMed ID: 27025445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroarytenoid Muscle Gene Expression in a Rat Model of Early-Onset Parkinson's Disease.
    Lechner SA; Kletzien H; Gammie SC; Kelm-Nelson CA
    Laryngoscope; 2021 Dec; 131(12):E2874-E2879. PubMed ID: 34057223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
    Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
    Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence of Neurobiological Changes in the Presymptomatic PINK1 Knockout Rat.
    Ferris CF; Morrison TR; Iriah S; Malmberg S; Kulkarni P; Hartner JC; Trivedi M
    J Parkinsons Dis; 2018; 8(2):281-301. PubMed ID: 29710734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atp13a2 expression in the periaqueductal gray is decreased in the Pink1 -/- rat model of Parkinson disease.
    Kelm-Nelson CA; Stevenson SA; Ciucci MR
    Neurosci Lett; 2016 May; 621():75-82. PubMed ID: 27057733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term oral kinetin does not protect against α-synuclein-induced neurodegeneration in rodent models of Parkinson's disease.
    Orr AL; Rutaganira FU; de Roulet D; Huang EJ; Hertz NT; Shokat KM; Nakamura K
    Neurochem Int; 2017 Oct; 109():106-116. PubMed ID: 28434973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of prodromal Parkinson's disease in young adult
    Lechner SA; Welsch JM; Pahapill NK; Kaldenberg TAR; Regenbaum A; Kelm-Nelson CA
    Front Behav Neurosci; 2022; 16():867958. PubMed ID: 36172466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of (-)-sesamin on motor and memory deficits in an MPTP-lesioned mouse model of Parkinson's disease treated with l-DOPA.
    Zhao TT; Shin KS; Kim KS; Park HJ; Kim HJ; Lee KE; Lee MK
    Neuroscience; 2016 Dec; 339():644-654. PubMed ID: 27789382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraperitoneal Administration of Forskolin Reverses Motor Symptoms and Loss of Midbrain Dopamine Neurons in PINK1 Knockout Rats.
    Vazquez-Mayorga E; Grigoruta M; Dagda R; Martinez B; Dagda RK
    J Parkinsons Dis; 2022; 12(3):831-850. PubMed ID: 34957950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of dopamine synaptic activity: degradation of 50-kHz ultrasonic vocalization in rats.
    Ciucci MR; Ahrens AM; Ma ST; Kane JR; Windham EB; Woodlee MT; Schallert T
    Behav Neurosci; 2009 Apr; 123(2):328-36. PubMed ID: 19331456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of oromotor and limb motor dysfunction in the DJ1 -/- model of Parkinson disease.
    Yang KM; Blue KV; Mulholland HM; Kurup MP; Kelm-Nelson CA; Ciucci MR
    Behav Brain Res; 2018 Feb; 339():47-56. PubMed ID: 29109055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential Expression of Striatal ΔFosB mRNA and FosB mRNA After Different Levodopa Treatment Regimens in a Rat Model of Parkinson's Disease.
    Palafox-Sanchez V; Sosti V; Ramirez-García G; Kulisevsky J; Aguilera J; Limón ID
    Neurotox Res; 2019 Apr; 35(3):563-574. PubMed ID: 30645726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of dopamine presynaptic markers and receptors in the striatum of DJ-1 and Pink1 knockout rats.
    Sun J; Kouranova E; Cui X; Mach RH; Xu J
    Neurosci Lett; 2013 Dec; 557 Pt B(0 0):123-8. PubMed ID: 24157858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphological and electrophysiological changes in intratelencephalic-type pyramidal neurons in the motor cortex of a rat model of levodopa-induced dyskinesia.
    Ueno T; Yamada J; Nishijima H; Arai A; Migita K; Baba M; Ueno S; Tomiyama M
    Neurobiol Dis; 2014 Apr; 64():142-9. PubMed ID: 24398173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice.
    Kitada T; Pisani A; Porter DR; Yamaguchi H; Tscherter A; Martella G; Bonsi P; Zhang C; Pothos EN; Shen J
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11441-6. PubMed ID: 17563363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats.
    Carta AR; Pinna A; Tronci E; Morelli M
    Neurology; 2003 Dec; 61(11 Suppl 6):S39-43. PubMed ID: 14663008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Entacapone potentiates the long-duration response but does not normalize levodopa-induced molecular changes.
    Marin C; Aguilar E; Mengod G; Cortés R; Rodríguez-Oroz MC; Obeso JA
    Neurobiol Dis; 2008 Dec; 32(3):340-8. PubMed ID: 18722529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotoxic effects of berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Shin KS; Choi HS; Zhao TT; Suh KH; Kwon IH; Choi SO; Lee MK
    Arch Pharm Res; 2013 Jun; 36(6):759-67. PubMed ID: 23539311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Striatal mRNA expression patterns underlying peak dose L-DOPA-induced dyskinesia in the 6-OHDA hemiparkinsonian rat.
    Smith LM; Parr-Brownlie LC; Duncan EJ; Black MA; Gemmell NJ; Dearden PK; Reynolds JN
    Neuroscience; 2016 Jun; 324():238-51. PubMed ID: 26968766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vocal and tongue exercise in early to mid-stage Parkinson disease using the Pink1-/- rat.
    Hoffmeister JD; Broadfoot CK; Schaen-Heacock NE; Lechner SA; Krasko MN; Nisbet AF; Russell J; Szot J; Glass TJ; Connor NP; Kelm-Nelson CA; Ciucci MR
    Brain Res; 2024 Aug; 1837():148958. PubMed ID: 38685371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.